The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis - Wikidata - awgldk - TriplyDB

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

http://www.wikidata.org/entity/Q29616121

about

Familial adenomatous polyposis COX-2 inhibition is neither necessary nor sufficient for celecoxib to suppress tumor cell proliferation and focus formation in vitro Thymoquinone attenuates tumor growth in ApcMin mice by interference with Wnt-signaling NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma Aspirin in the Chemoprevention of Colorectal Neoplasia: An Overview NSAIDS or paracetamol, alone or combined with opioids, for cancer pain Anti-inflammatory agents for preventing the progression of cervical intraepithelial neoplasia NSAIDS or paracetamol, alone or combined with opioids, for cancer pain Non steroidal anti-inflammatory drugs (NSAID) and aspirin for preventing colorectal adenomas and carcinomas The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-delta to induce apoptosis in colorectal cancer cells 3-Phosphoinositide-dependent protein kinase-1-mediated IkappaB kinase beta (IkkB) phosphorylation activates NF-kappaB signaling Protein kinase A-mediated 14-3-3 association impedes human Dapper1 to promote dishevelled degradation Regulation of inflammation in cancer by eicosanoids Molecular origins of cancer: Molecular basis of colorectal cancer Colorectal cancer chemoprevention: is this the future of colorectal cancer prevention?Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency In vitro and in vivo evaluation of NCX 4040 cytotoxic activity in human colon cancer cell lines Diosgenin, a plant steroid, induces apoptosis in human rheumatoid arthritis synoviocytes with cyclooxygenase-2 overexpression Allellic variants in regulatory regions of cyclooxygenase-2: association with advanced colorectal adenoma.A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent Cancers Understanding the molecular mechanisms of cancer prevention by dietary phytochemicals: From experimental models to clinical trials Mouse models of intestinal cancer Molecular cancer prevention: Current status and future directions Duodenal adenoma surveillance in patients with familial adenomatous polyposis Children's Oncology Group's 2013 blueprint for research: Soft tissue sarcomas Chemoprevention in familial adenomatous polyposis Chemopreventive drugs: mechanisms via inhibition of cancer stem cells in colorectal cancer Microbiome, inflammation, and cancer Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial.Prostaglandin E receptor 4 (EP4) promotes colonic tumorigenesis.Effect of Sulindac and Erlotinib vs Placebo on Duodenal Neoplasia in Familial Adenomatous Polyposis: A Randomized Clinical Trial.Role of Urinary Biomarkers in the Diagnosis of Adenoma and Colorectal Cancer: A Systematic Review and Meta-Analysis Aberrant regulation of Wnt signaling in hepatocellular carcinoma Effects of supplemental vitamin D and calcium on normal colon tissue and circulating biomarkers of risk for colorectal neoplasms The evolving role of nonsteroidal anti-inflammatory drugs in colon cancer prevention: a cause for optimism Increased NF-kappaB DNA binding but not transcriptional activity during apoptosis induced by the COX-2-selective inhibitor NS-398 in colorectal carcinoma cells Use of NSAIDs for the chemoprevention of colorectal cancer Non steroidal anti-inflammatory drugs and COX-2 inhibitors as anti-cancer therapeutics: hypes, hopes and reality Primary and secondary prevention in colorectal cancer Cyclooxygenase-2 and gastric carcinogenesis

P2860

Q21202887-B4E5D42E-A76F-41F0-A57C-1BC57F3CF640 Q21245723-8575E0EF-96F4-4428-9C5F-2EC1FA96BBC7 Q21245755-FC27E906-782A-4B74-AB70-149CB1759FAF Q21563424-4AAB2EC5-9A77-4606-8DB2-F2CF237B35EF Q22306433-2010FA19-CC54-4AAB-8941-D449A39DBF91 Q24186655-91D36641-8417-44EE-8BF0-8C227C48A834 Q24241893-878395A3-6D0D-4098-A97F-9CE6F9EB9854 Q24246917-08A66410-9C7E-4950-BC79-2B44AC58BED9 Q24247367-87F68BED-3D25-4877-B38D-FD2916127FE5 Q24314509-B29F0A3F-5E1F-46B0-897E-266F28EC071A Q24337691-BC4279AC-D010-4AD8-8E84-B5D26D2BD08D Q24338245-7C540B5E-1E7B-4FB9-8610-972DCD83A910 Q24564308-F576A1EE-DB86-4251-89B1-ED678F681EB6 Q24617331-8554CA3D-0BF8-418B-B138-C052EDE39E68 Q24620457-73A6F529-EA44-4404-BB51-F0302AD36464 Q24650990-EBF28BF7-31DC-4081-A16E-B09E1D4230D2 Q24792522-2DC56B73-2E52-4242-A3F5-36C70465DB58 Q24805647-050034D0-BB54-4DC3-915B-B706261BAEE3 Q25255846-DF403A13-B499-423F-8388-26358E670A1C Q26739665-DA26334F-9EC3-404B-9B50-0964B44E7543 Q26765196-4284E6D4-EBCF-4255-BC88-C638BFFA4B79 Q26785563-742EDF8D-25F2-4935-BACA-F5D9198FE87C Q26797207-F9430477-648C-4D39-8ECE-7C90CA494084 Q26799039-B8CF7F4A-856E-4645-8EF9-6A6B782C9E16 Q26825000-D11E6154-0634-4BD1-8F5B-73F55B995216 Q27023845-791CF469-BB7E-4C17-B846-8167750749B0 Q27026428-974CD2EC-69B3-40E6-BEA8-0B1CBAB528BF Q27027582-81B2ADCA-72DC-474E-A804-44F8C4481776 Q27313312-84B4CF89-A812-449F-8833-7D54CEBD21B4 Q27340480-C9AE0166-0B2D-4E2F-A610-992B6E01D840 Q27347642-0EA5338E-481E-43D7-AAC5-FC40C379479D Q28067664-2C1268CA-353F-473C-8EA8-2BD10F617DF2 Q28079789-CD75CA8D-9C33-450E-999D-6C1DC8650E1E Q28083343-C657BCE8-5BF5-45C4-BB77-B44A61D4B341 Q28087427-7D7E409E-F392-48C9-9DBC-5FA288ED108D Q28165527-A6665315-7134-4B94-8B80-5945D86F07E8 Q28165741-C0B616EE-6DDA-493B-8967-E6D4C31C9821 Q28166312-B23D8EE7-7472-4B33-B96F-D5DC4F64444C Q28167290-328918F3-A0DF-45C6-9814-684098C4690B Q28184447-29209DFC-70BB-4136-A283-7DBAD380E31C

P2860

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

http://www.wikidata.org/entity/Q29616121

description

2000 nî lūn-bûn

@nan

2000 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

@ast

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

@en

type

label

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

@ast

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

@en

prefLabel

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

@ast

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

@en

P1433

Q29616121-C611244E-6311-4FF1-9723-CA1C9B56072B

P1476

Q29616121-894C4D16-FC03-4DF4-8409-2A610C59111C

P2093

Q29616121-0A506568-0850-4547-9469-5E0393FD037F

Q29616121-175FFEC3-F50A-4B58-9A3E-734E6610EE8F

Q29616121-1C4875A0-25F1-4080-9ADD-2EA9CAE89495

Q29616121-24F72CD2-47C0-4FD6-AC99-9BD7FA339F54

Q29616121-277ACE70-0DA7-4910-9870-777AF8FAD0E5

Q29616121-2E8A8BE9-365B-456F-9583-459B772108D9

Q29616121-36910AA5-C605-4257-AE5E-54F29F8D8D69

Q29616121-3EEA6B1B-70F4-4193-9E7E-35CDCEB868DC

Q29616121-521B1A68-4B1D-4307-B082-FA808A462548

Q29616121-5C2F84DD-A3F2-4042-8CD8-A3DDE1577B6E

P304

Q29616121-8177752E-9EBE-4F5F-A71C-C3E3170A0FAF

P31

Q29616121-BF9C4DB1-BFEE-4538-9745-DBAFB10D0FFC

P3181

Q29616121-752C68BB-CAB0-4BB6-ABE8-92E2B0793547

P356

Q29616121-A90E5EDE-5C1C-4A3C-AB43-50B5BD797B4F

P407

Q29616121-12F3B536-05B7-46A3-A71B-A55272BEF153

P433

Q29616121-9E4680C2-16DA-41FD-828C-4C3A0DBB8E59

P478

Q29616121-7B86D604-E511-4975-A984-0AC7963A68BA

P577

Q29616121-7969FEB7-475C-45B2-8935-48416FF28868

P5875

Q29616121-B3564DE2-7399-4959-8BCD-7EB1DB540F68

P698

Q29616121-FADC56BC-B2B1-47C5-BE9A-90A74549CE8D

P3181

P356

NEJM200006293422603

P1433

The New England Journal of Medicine

P1476

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

@en

P2093

Abbruzzese J

http://www.w3.org/2001/XMLSchema#string

DuBois RN

http://www.w3.org/2001/XMLSchema#string

Fujimura T

http://www.w3.org/2001/XMLSchema#string

Godio L

http://www.w3.org/2001/XMLSchema#string

Gordon GB

http://www.w3.org/2001/XMLSchema#string

Hawk E

http://www.w3.org/2001/XMLSchema#string

Hittelman WN

http://www.w3.org/2001/XMLSchema#string

Jester SL

http://www.w3.org/2001/XMLSchema#string

Kelloff G

http://www.w3.org/2001/XMLSchema#string

King KL

http://www.w3.org/2001/XMLSchema#string

P304

1946-52

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3076181

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJM200006293422603

http://www.w3.org/2001/XMLSchema#string

P407

P433

26

http://www.w3.org/2001/XMLSchema#string

P478

342

http://www.w3.org/2001/XMLSchema#string

P577

2000-06-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12445003

http://www.w3.org/2001/XMLSchema#string

P698

10874062

http://www.w3.org/2001/XMLSchema#string